What We Do
What we do
We are developing Prolanta™, a targeted therapeutic protein for the treatment of ovarian, breast and other cancers.
Oncolix has chosen BioVectra, Inc. to perform the manufacturing of Prolanta. BioVectra is the largest Canadian...
oncolix welcomes intrest in developing a technical and financial partnership with both public and private entities